Disease-free survival after autologous bone marrow transplantation in patients with acute myelogenous leukemia.

Abstract:

:Autologous bone marrow transplantation (ABMT) makes it possible to escalate the dose of cytotoxic treatment to a lethal range. Disease-free survival (DFS) following myeloablative therapy and ABMT has been shown to be superior to conventional treatment in high risk patients with acute myelogenous leukemia (AML). It was the purpose of the present study to compare hematopoietic reconstitution, actuarial DFS, and relapse rate of patients transplanted in first complete remission (CR) of AML with those in second or subsequent CR, and to evaluate transplant related mortality. Fifty-two patients with AML, 22 in first CR (low risk) and 30 in second or subsequent CR (high risk), underwent total body irradiation (12.1 to 16.7 Gy) and cyclophosphamide (CY) treatment (200 mg/kg) followed by ABMT. The autograft was incubated with the active CY derivative Mafosfamide (ASTA Werke, Bielefeld, Federal Republic of Germany) to reduce the number of possibly contaminating clonogenic tumor cells. All patients showed three lineage engraftments with platelet recovery observed as being the slowest. The transplant related death rate was low at 5.8%. There was no significant difference in the kinetics of polymorphonuclear (PMN) cell or platelet reconstitution between the low and high risk patient subgroups. The estimated probability of DFS (relapse) after ABMT in first CR was 61% (36%) compared with 34% (65%) in second or subsequent CR, the longest follow-up being 55 months and 57 months, respectively (median follow-up 31 months and 19 months, respectively). ABMT offers a stable long-term DFS when performed in first CR with no relapses occurring in over a year after transplantation. Six later relapses, however, were seen after ABMT in second or subsequent CR, although DFS was not statistically different from that of first remission patients (P = .72).

journal_name

Blood

journal_title

Blood

authors

Körbling M,Hunstein W,Fliedner TM,Cayeux S,Dörken B,Fehrentz D,Haas R,Ho AD,Keilholz U,Knauf W

subject

Has Abstract,Author List Incomplete

pub_date

1989-11-01 00:00:00

pages

1898-904

issue

6

eissn

0006-4971

issn

1528-0020

journal_volume

74

pub_type

杂志文章

相关文献

BLOOD文献大全
  • The nonexpression of CD36 on reticulocytes and mature red blood cells does not modify the clinical course of patients with sickle cell anemia.

    abstract::It is thought that an increase in the adhesion of circulating reticulocytes to the vascular endothelium may initiate the vascular occlusion underlying the painful crises and organ failures typical of sickle cell disease (SCD). At least 2 receptors, usually present on reticulocytes, seem to be involved in this adhesion...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v98.4.966

    authors: Lee K,Gane P,Roudot-Thoraval F,Godeau B,Bachir D,Bernaudin F,Cartron JP,Galactéros F,Bierling P

    更新日期:2001-08-15 00:00:00

  • Human allogeneic stem cell maintenance and differentiation in a long-term multilineage SCID-hu graft.

    abstract::The ability to determine the functional capacity of putative human hematopoietic stem cell (HSC) populations requires in vivo assays in which long-term multilineage differentiation can be assessed. We hypothesized that if human fetal bone was transplanted adjacent to a fetal thymus fragment in severe combined immunode...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Fraser CC,Kaneshima H,Hansteen G,Kilpatrick M,Hoffman R,Chen BP

    更新日期:1995-09-01 00:00:00

  • Randomized trial of filgrastim versus chemotherapy and filgrastim mobilization of hematopoietic progenitor cells for rescue in autologous transplantation.

    abstract::Peripheral blood cell (PBC) rescue has become the mainstay for autologous transplantation in patients with lymphoma, multiple myeloma, and solid tumors. Different methods of hematopoietic progenitor cell (HPC) mobilization are in use without an established standard. Forty-seven patients with relapsed or refractory lym...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1182/blood.v98.7.2059

    authors: Narayanasami U,Kanteti R,Morelli J,Klekar A,Al-Olama A,Keating C,O'Connor C,Berkman E,Erban JK,Sprague KA,Miller KB,Schenkein DP

    更新日期:2001-10-01 00:00:00

  • Experimental transmission and pathogenesis of immunodeficiency syndrome in cats.

    abstract::We describe the identification, experimental transmission, and pathogenesis of a naturally occurring powerfully immunosuppressive isolate of feline leukemia virus (designated here as FeLV-FAIDS) which induces fatal acquired immunodeficiency syndrome (AIDS) in 100% (25 of 25) of persistently viremic experimentally infe...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Hoover EA,Mullins JI,Quackenbush SL,Gasper PW

    更新日期:1987-12-01 00:00:00

  • A novel PAX5-ELN fusion protein identified in B-cell acute lymphoblastic leukemia acts as a dominant negative on wild-type PAX5.

    abstract::We report a novel t(7;9)(q11;p13) translocation in 2 patients with B-cell acute lymphoblastic leukemia (B-ALL). By fluorescent in situ hybridization and 3' rapid amplification of cDNA ends, we showed that the paired box domain of PAX5 was fused with the elastin (ELN) gene. After cloning the full-length cDNA of the chi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-05-025221

    authors: Bousquet M,Broccardo C,Quelen C,Meggetto F,Kuhlein E,Delsol G,Dastugue N,Brousset P

    更新日期:2007-04-15 00:00:00

  • Infants with acute lymphoblastic leukemia and a germline MLL gene are highly curable with use of chemotherapy alone: results from the Japan Infant Leukemia Study Group.

    abstract::Although infants with acute lymphoblastic leukemia (ALL) and a germline MLL gene have a better prognosis than comparable infants with a rearranged MLL gene, their optimal therapy is controversial. In 2 consecutive studies, conducted between 1996 and 2002, we treated 22 cases of infant ALL with germline MLL using chemo...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1182/blood-2005-11-4728

    authors: Nagayama J,Tomizawa D,Koh K,Nagatoshi Y,Hotta N,Kishimoto T,Takahashi Y,Kuno T,Sugita K,Sato T,Kato K,Ogawa A,Nakahata T,Mizutani S,Horibe K,Ishii E,Japan Infant Leukemia Study Group.

    更新日期:2006-06-15 00:00:00

  • Myeloma cells upregulate interleukin-6 secretion in osteoblastic cells through cell-to-cell contact but downregulate osteocalcin.

    abstract::Previous studies have shown that bone marrow, especially the bone microenvironment, may play an important role in the pathogenesis of multiple myeloma (MM). To elucidate the relationship between myeloma cells and bone cells, mainly osteoblasts, we have established a coculture system between two interleukin-6 (IL-6)-de...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Barillé S,Collette M,Bataille R,Amiot M

    更新日期:1995-10-15 00:00:00

  • Exogenous insulin-like growth factor 1 enhances thymopoiesis predominantly through thymic epithelial cell expansion.

    abstract::Insulin-like growth factor 1 (IGF-1) enhances thymopoiesis but given the broad distribution of IGF-1 receptors (IGF-1Rs), its mechanism of action has remained unclear. To identify points of thymic regulation by IGF-1, we examined its effects on T-cell precursors, thymocytes, and thymic epithelial cells (TECs) in norma...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-04-149435

    authors: Chu YW,Schmitz S,Choudhury B,Telford W,Kapoor V,Garfield S,Howe D,Gress RE

    更新日期:2008-10-01 00:00:00

  • Distinct gene expression patterns in chronic lymphocytic leukemia defined by usage of specific VH genes.

    abstract::The mutation status and usage of specific VH genes such as V3-21 and V1-69 are potentially independent pathogenic and prognostic factors in chronic lymphocytic leukemia (CLL). To investigate the role of antigenic stimulation, we analyzed the expression of genes involved in B-cell receptor (BCR) signaling/activation, c...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-04-1483

    authors: Kienle D,Benner A,Kröber A,Winkler D,Mertens D,Bühler A,Seiler T,Jäger U,Lichter P,Döhner H,Stilgenbauer S

    更新日期:2006-03-01 00:00:00

  • Trafficking of the major virulence factor to the surface of transfected P. falciparum-infected erythrocytes.

    abstract::After invading human red blood cells (RBCs) the malaria parasite Plasmodium falciparum remodels the host cell by trafficking proteins to the RBC compartment. The virulence protein P. falciparum erythrocyte membrane protein 1 (PfEMP1) is responsible for cytoadherence of infected cells to host endothelial receptors. Thi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-12-4666

    authors: Knuepfer E,Rug M,Klonis N,Tilley L,Cowman AF

    更新日期:2005-05-15 00:00:00

  • Somatic mosaicism for oncogenic NRAS mutations in juvenile myelomonocytic leukemia.

    abstract::Juvenile myelomonocytic leukemia (JMML) is a rare pediatric myeloid neoplasm characterized by excessive proliferation of myelomonocytic cells. Somatic mutations in genes involved in GM-CSF signal transduction, such as NRAS, KRAS, PTPN11, NF1, and CBL, have been identified in more than 70% of children with JMML. In the...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-02-406090

    authors: Doisaki S,Muramatsu H,Shimada A,Takahashi Y,Mori-Ezaki M,Sato M,Kawaguchi H,Kinoshita A,Sotomatsu M,Hayashi Y,Furukawa-Hibi Y,Yamada K,Hoshino H,Kiyoi H,Yoshida N,Sakaguchi H,Narita A,Wang X,Ismael O,Xu Y,Nishio N

    更新日期:2012-08-16 00:00:00

  • Immunostimulatory conventional dendritic cells evolve into regulatory macrophage-like cells.

    abstract::Dendritic cell (DC) homeostasis in peripheral tissues reflect a balance between DC generation, migration, and death. The current model of DC ontogeny indicates that pre-cDCs are committed to become terminal conventional DCs (cDCs). Here, we report the unexpected finding that proliferating immunostimulatory CD11c(+) MH...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-11-392894

    authors: Diao J,Mikhailova A,Tang M,Gu H,Zhao J,Cattral MS

    更新日期:2012-05-24 00:00:00

  • T and B lymphocyte antigen-positive null cell leukemias.

    abstract::To clarify the nature of null cell acute lymphoblastic leukemia (ALL) we tested null lymphoblasts and other leukemic cells for human T and B lymphocyte antigens detected by reciprocally absorbed rabbit antisera prepared against autologous T and B lymphoblast cell lines HSB-2 and SB. Blasts from 4 of 4 patients with T ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Kaplan J,Ravindranath Y,Peterson WD Jr

    更新日期:1977-03-01 00:00:00

  • Second to none.

    abstract::In this issue of Blood, Usmani et al provide important information on second primary malignancies in patients treated with thalidomide and lenalidomide in the Arkansas total therapy trials. ...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2012-07-439158

    authors: Rajkumar SV

    更新日期:2012-08-23 00:00:00

  • Diferric transferrin regulates transferrin receptor 2 protein stability.

    abstract::Transferrin receptor 2 (TfR2) is a type 2 transmembrane protein expressed in hepatocytes that binds iron-bound transferrin (Tf). Mutations in TfR2 cause one form of hereditary hemochromatosis, a disease in which excessive absorption of dietary iron can lead to liver cirrhosis, diabetes, arthritis, and heart failure. T...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-06-2477

    authors: Johnson MB,Enns CA

    更新日期:2004-12-15 00:00:00

  • Constitutive expression of Mpl ligand transcripts during thrombocytopenia or thrombocytosis.

    abstract::Mpl ligand (thrombopoietin [TPO]) is the physiological regulator of platelet production. In mice, mRNA encoding the Mpl ligand (Mpl-L) is predominantly found by Northern blot analysis in the liver and kidney. To investigate the mode of regulation of the Mpl-L gene, we have developed several experimental models of seve...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Cohen-Solal K,Villeval JL,Titeux M,Lok S,Vainchenker W,Wendling F

    更新日期:1996-10-01 00:00:00

  • Ligand-induced EpoR internalization is mediated by JAK2 and p85 and is impaired by mutations responsible for primary familial and congenital polycythemia.

    abstract::Epo-induced endocytosis of EpoR plays important roles in the down-regulation of EpoR signaling and is the primary means that regulates circulating Epo concentrations. Here we show that cell-surface EpoR is internalized via clathrin-mediated endocytosis. Both JAK2 kinase activity and EpoR cytoplasmic tyrosines are impo...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-09-179572

    authors: Sulahian R,Cleaver O,Huang LJ

    更新日期:2009-05-21 00:00:00

  • Inhibition of tartrate-resistant acid phosphatase gene expression by hemin and protoporphyrin IX. Identification of a hemin-responsive inhibitor of transcription.

    abstract::Tartrate-resistant acid phosphatase (TRAP) is an iron-containing protein encoded by the same gene that codes for uteroferrin, a placental iron transport protein. In human peripheral mononuclear cells, TRAP expression is inhibited by both hemin (ferric protoporphyrin IX) and protoporphyrin IX. Nuclear run-on assays con...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Reddy SV,Alcantara O,Roodman GD,Boldt DH

    更新日期:1996-09-15 00:00:00

  • Coexistence of multiple mechanisms of PT523 resistance in human leukemia cells harboring 3 reduced folate carrier alleles: transcriptional silencing, inactivating mutations, and allele loss.

    abstract::The reduced folate carrier (RFC) is the dominant route for the uptake of various antifolates including PT523, a potent dihydrofolate reductase inhibitor (Ki = 0.35 pM) and an excellent transport substrate of the RFC (Kt = 0.7 microM). Here, we describe the multiple mechanisms of RFC inactivation in human leukemia PT52...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-10-4048

    authors: Kaufman Y,Ifergan I,Rothem L,Jansen G,Assaraf YG

    更新日期:2006-04-15 00:00:00

  • Involvement of oxygen-sensing pathways in physiologic and pathologic erythropoiesis.

    abstract::Red blood cells deliver O(2) from the lungs to every cell in the human body. Reduced tissue oxygenation triggers increased production of erythropoietin by hypoxia-inducible factor 1 (HIF-1), which is a transcriptional activator composed of an O(2)-regulated alpha subunit and a constitutively expressed beta subunit. Hy...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2009-05-189985

    authors: Semenza GL

    更新日期:2009-09-03 00:00:00

  • Clonal chromosomal abnormalities appearing in Philadelphia chromosome-negative metaphases during CML treatment.

    abstract::Clonal chromosomal abnormalities in Philadelphia chromosome-negative (CCA/Ph-) metaphases emerge as patients with chronic phase chronic myeloid leukemia (CP-CML) are treated with tyrosine kinase inhibitors (TKIs). We assessed the characteristics and prognostic impact of 598 patients with CP-CML treated on clinical tri...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2017-07-792143

    authors: Issa GC,Kantarjian HM,Gonzalez GN,Borthakur G,Tang G,Wierda W,Sasaki K,Short NJ,Ravandi F,Kadia T,Patel K,Luthra R,Ferrajoli A,Garcia-Manero G,Rios MB,Dellasala S,Jabbour E,Cortes JE

    更新日期:2017-11-09 00:00:00

  • Anti-IL6-receptor-alpha (tocilizumab) does not inhibit human monocyte-derived dendritic cell maturation or alloreactive T-cell responses.

    abstract::Significant comorbidites and lethality complicate GVHD and its treatment. Targeting the cytokine milieu may improve GVHD control; and IL6 is an attractive candidate, given its role in dendritic cell activation and T-cell differentiation. Tocilizumab is a humanized mAb to IL6-receptor-α (IL6R-α), which is Food and Drug...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-06-363390

    authors: Betts BC,St Angelo ET,Kennedy M,Young JW

    更新日期:2011-11-10 00:00:00

  • Striking inverse correlation between IgG anti-F(ab')2 and autoantibody production in patients with cold agglutination.

    abstract::Previous experiments showed that the physiologic IgG anti-F(ab')2 antibody suppresses the response of human autoreactive B cells. In the present study, we analyzed the IgG anti-F(ab')2 antibody in 293 patients with cold agglutination (CA). Their average IgG anti-F(ab')2 titer was not much different (211 +/- 8.3) from ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Terness P,Kirschfink M,Navolan D,Dufter C,Kohl I,Opelz G,Roelcke D

    更新日期:1995-01-15 00:00:00

  • Sequence analysis of β-subunit genes of the 20S proteasome in patients with relapsed multiple myeloma treated with bortezomib or dexamethasone.

    abstract::Variations within proteasome β (PSMB) genes, which encode the β subunits of the 20S proteasome, may affect proteasome function, assembly, and/or binding of proteasome inhibitors. To investigate the potential association between PSMB gene variants and treatment-emergent resistance to bortezomib and/or long-term outcome...

    journal_title:Blood

    pub_type: 杂志文章,随机对照试验

    doi:10.1182/blood-2012-05-426924

    authors: Lichter DI,Danaee H,Pickard MD,Tayber O,Sintchak M,Shi H,Richardson PG,Cavenagh J,Bladé J,Façon T,Niesvizky R,Alsina M,Dalton W,Sonneveld P,Lonial S,van de Velde H,Ricci D,Esseltine DL,Trepicchio WL,Mulligan G,And

    更新日期:2012-11-29 00:00:00

  • Cellular therapies for graft-versus-host disease: a tale of tissue repair and tolerance.

    abstract::The success of allogeneic hematopoietic cell transplantation depends heavily on the delicate balance between the activity of the donor immune system against malignant and nonmalignant cells of the recipient. Abrogation of alloreactivity will lead to disease relapse, whereas untamed allo-immune responses will lead to l...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019000951

    authors: Voermans C,Hazenberg MD

    更新日期:2020-07-23 00:00:00

  • Potentially oncogenic B-cell activation-induced smaller isoforms of FOXP1 are highly expressed in the activated B cell-like subtype of DLBCL.

    abstract::The FOXP1 forkhead transcription factor is targeted by recurrent chromosome translocations in several subtypes of B-cell non-Hodgkin lymphomas, where high-level FOXP1 protein expression has been linked to a poor prognosis. Western blotting studies of diffuse large B-cell lymphoma (DLBCL) cell lines unexpectedly identi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-09-115113

    authors: Brown PJ,Ashe SL,Leich E,Burek C,Barrans S,Fenton JA,Jack AS,Pulford K,Rosenwald A,Banham AH

    更新日期:2008-03-01 00:00:00

  • The Senegal DNA haplotype is associated with the amelioration of anemia in African-American sickle cell anemia patients.

    abstract::We have previously determined that in African sickle cell anemia (SS) patients three different beta-like globin gene cluster haplotypes are associated with different percent G gamma (one of the two types of non-alpha chains comprising hemoglobin F [HbF]), mean percent HbF, and percent dense cells. We report now that i...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Nagel RL,Erlingsson S,Fabry ME,Croizat H,Susuka SM,Lachman H,Sutton M,Driscoll C,Bouhassira E,Billett HH

    更新日期:1991-03-15 00:00:00

  • A novel cause of mild/moderate hemophilia A: mutations scattered in the factor VIII C1 domain reduce factor VIII binding to von Willebrand factor.

    abstract::The mechanisms responsible for the low factor VIII (fVIII) activity in the plasma of patients with mild/moderate hemophilia A are poorly understood. In such patients, we have identified a series of fVIII mutations (Ile2098Ser, Ser2119Tyr, Asn2129Ser, Arg2150His, and Pro2153Gln) clustered in the C1 domain and associate...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Jacquemin M,Lavend'homme R,Benhida A,Vanzieleghem B,d'Oiron R,Lavergne JM,Brackmann HH,Schwaab R,VandenDriessche T,Chuah MK,Hoylaerts M,Gilles JG,Peerlinck K,Vermylen J,Saint-Remy JM

    更新日期:2000-08-01 00:00:00

  • Tissue factor pathway inhibitor is required for cerebrovascular development in mice.

    abstract::Tissue factor pathway inhibitor (TFPI) inhibits proteases in the blood coagulation cascade that lead to the production of thrombin, including prothrombinase (factor Xa [FXa]/FVa), the catalytic complex that directly generates thrombin. Thus, TFPI and FV are directly linked in regulating the procoagulant response. Stud...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2020006054

    authors: Maroney SA,Westrick RJ,Cleuren AC,Martinez ND,Siebert AE,Zogg M,Ginsburg D,Weiler H,Mast AE

    更新日期:2021-01-14 00:00:00

  • Evaluation of the safety and pharmacodynamics of Hematide, a novel erythropoietic agent, in a phase 1, double-blind, placebo-controlled, dose-escalation study in healthy volunteers.

    abstract::Hematide is an investigational pegylated synthetic peptide that stimulates erythropoiesis in animal models and is being developed for the treatment of anemia associated with chronic renal failure and cancer. This study evaluated the safety and pharmacodynamics of single, intravenous doses (0.025, 0.05, and 0.1 mg/kg) ...

    journal_title:Blood

    pub_type: 杂志文章,随机对照试验

    doi:10.1182/blood-2006-04-015818

    authors: Stead RB,Lambert J,Wessels D,Iwashita JS,Leuther KK,Woodburn KW,Schatz PJ,Okamoto DM,Naso R,Duliege AM

    更新日期:2006-09-15 00:00:00